ACVR2B Gene

📖 Wiki Page

gene1693 wordssynced 2026-04-02

ACVR2B Gene

| Property | Value |
|----------|-------|
| Gene Symbol | ACVR2B |
| Full Name | Activin A Receptor Type 2B |
| Chromosomal Location | 3p22.2 |
| NCBI Gene ID | 102 |
| OMIM ID | 602730 |
| Ensembl ID | ENSG00000121905 |
| UniProt ID | Q13705 |
| Encoded Protein | Activin receptor type-2B |
| Protein Family | TGF-beta receptor type II family |
| Molecular Weight | ~60 kDa |
| Tissue Expression | Brain, heart, lung, liver, skeletal muscle |

</div>

Overview

ACVR2B (Activin A Receptor Type 2B) encodes a type I serine/threonine kinase receptor that binds activin and other TGF-beta superfamily ligands. ACVR2B is a component of the larger TGF-beta signaling network, which plays essential roles in embryonic development, tissue homeostasis, and cellular function throughout the nervous system. The TGF-beta superfamily includes activins, inhibins, BMPs (bone morphogenetic proteins), and Nodal, each with distinct and overlapping functions [@acvr2b_tgfbeta].

ACVR2B functions as a type II receptor, meaning it binds ligand directly and initiates signaling by recruiting and phosphorylating type I receptors (also called ALKs - activin receptor-like kinases). The activated type I receptor then phosphorylates receptor-regulated SMADs (R-SMADs), which translocate to the nucleus to regulate gene expression. For activin signaling, the primary pathway involves SMAD2 and SMAD3, which form complexes with SMAD4 to regulate transcription [@acvr2b_smads].

...

ACVR2B Gene

</div>

Overview

In the nervous system, ACVR2B-mediated signaling regulates neural development, synaptic plasticity, neurogenesis, and neuroprotection. Dysregulation of activin/ACVR2B signaling is implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, making it a subject of significant research interest [@acvr2b_ad].

Function

Receptor Structure and Activation

ACVR2B is a transmembrane receptor composed of extracellular, transmembrane, and intracellular kinase domains [@acvr2b_receptors]:

Extracellular Domain

Ligand binding domain (~200 amino acids)
Contains cysteine residues for disulfide bonds
N-glycosylation sites for proper folding

Transmembrane Domain

Single pass through the membrane
anchors receptor in plasma membrane
Connects extracellular and intracellular domains

Intracellular Domain

Serine/threonine kinase domain
C-terminal tail with regulatory sites
Multiple phosphorylation sites

Activation Mechanism

Ligand binding: Activin A binds to ACVR2B extracellular domain

Receptor recruitment: Type I receptor (ACVR1/ALK4) is recruited to the complex

Phosphorylation: ACVR2B phosphorylates the type I receptor

SMAD activation: R-SMADs are phosphorylated

Nuclear translocation: SMAD complexes enter the nucleus

SMAD Signaling

The primary downstream effectors of ACVR2B are SMAD2 and SMAD3 [@acvr2b_smads]:

SMAD2/3 Activation

Type I receptor phosphorylates SMAD2/3 at C-terminal serines
Phosphorylated SMADs form complexes with SMAD4
Complexes translocate to the nucleus

Transcriptional Regulation

SMAD complexes regulate gene expression by:

Binding to SMAD-binding elements (SBEs)
Recruiting co-activators or co-repressors
Chromatin remodeling

SMAD7 Feedback

SMAD7 is an inhibitory SMAD that provides negative feedback [@acvr2b_smad7]:

Competes with SMAD2/3 for type I receptor binding
Recruits ubiquitin ligases for receptor degradation
Fine-tunes signaling intensity

Neural Development

ACVR2B signaling is crucial for multiple aspects of neural development [@acvr2b_development]:

Neurogenesis

Regulates neural progenitor cell proliferation
Controls differentiation timing
Promotes neuronal commitment

Neuronal Migration

Guides neuronal migration during cortical development
Controls radial migration
Regulates tangential migration

Axon Guidance

Provides guidance cues for developing axons
Responds to extracellular gradients
Controls pathfinding decisions

Synaptogenesis

Regulates synapse formation
Controls synaptic connectivity
Establishes appropriate circuits

Synaptic Plasticity

ACVR2B signaling modulates synaptic plasticity in the adult brain [@acvr2b_synapse]:

Long-Term Potentiation (LTP)

Activin enhances LTP in hippocampus
ACVR2B is required for LTP maintenance
SMAD signaling participates in LTP consolidation

Long-Term Depression (LTD)

Activin modulates LTD induction
ACVR2B regulates AMPA receptor trafficking
Participates in depression mechanisms

Synaptic Structure

Controls dendritic spine morphology
Regulates spine density
Modulates synaptic stability

Hippocampal Function

ACVR2B is highly expressed in the hippocampus where it regulates [@acvr2b_hippocampus]:

Memory Formation

Required for spatial memory
Involved in contextual memory
Supports consolidation

Adult Neurogenesis

Promotes NPC proliferation in dentate gyrus
Controls differentiation
Supports new neuron integration

Circuit Function

Modulates CA3-CA1 connectivity
Regulates entorhinal cortical inputs
Controls inhibitory/excitatory balance

Neuroprotection

ACVR2B signaling has neuroprotective properties:

Survival Promotion

Activin promotes neuronal survival
ACVR2B mediates anti-apoptotic effects
Protects against excitotoxicity

Oxidative Stress

Reduces oxidative damage
Enhances antioxidant defenses
Protects mitochondria

Inflammation Modulation

Regulates neuroinflammatory responses
Controls microglial activation
Reduces cytokine production

Disease Associations

Alzheimer's Disease

ACVR2B is relevant to Alzheimer's disease through multiple mechanisms [@acvr2b_ad]:

TGF-beta Signaling Dysregulation

TGF-beta signaling is altered in AD brain
Activin levels are changed in AD
ACVR2B expression may be affected

Neuroprotection

Activin/ACVR2B is neuroprotective against Aβ toxicity
Loss of signaling may increase vulnerability
Restoring signaling may be therapeutic

Synaptic Function

Activin modulates synaptic plasticity in AD
ACVR2B signaling is impaired
Contributes to synaptic failure

Neuroinflammation

Activin regulates inflammatory responses
ACVR2B dysfunction may exacerbate inflammation

Parkinson's Disease

ACVR2B has connections to Parkinson's disease [@acvr2b_pd]:

Dopaminergic Neurons

ACVR2B is expressed in substantia nigra
Activin promotes dopaminergic neuron survival
Loss of signaling may contribute to degeneration

α-Synuclein

TGF-beta signaling interacts with α-synuclein
ACVR2B may affect aggregation
Protective effects against toxicity

Neuroinflammation

Activin modulates microglial activation
May influence inflammatory environment

Amyotrophic Lateral Sclerosis

ACVR2B has relevance to ALS:

Motor neuron survival
Glial interactions
[Neuroinflammation](/mechanisms/neuroinflammation)

Stroke and CNS Injury

ACVR2B is protective in CNS injury:

Ischemic damage
Traumatic injury
Potential for regeneration

Expression

Tissue Distribution

ACVR2B is expressed in many tissues:

Brain (neurons, glia)
Heart
Lung
Liver
Skeletal muscle
Kidney

Brain Expression

In the brain, ACVR2B is expressed in:

Neurons

Pyramidal neurons in cortex
Hippocampal neurons (CA1, CA3, dentate gyrus)
Dopaminergic neurons in substantia nigra
Cerebellar Purkinje cells

Glia

Astrocytes [@acvr2b_astrocyte]- [Oligodendrocytes](/cell-types/oligodendrocytes)r2b_microglia]
[Oligodendrocytes](/cell-types/oligodendrocytes)

Subcellular Localization

Plasma membrane: Primary receptor location
Endosomes: Signaling compartments
Nucleus: Some SMAD-dependent nuclear localization

Regulation

ACVR2B expression is regulated:

Transcription: Activity-dependent
Post-translation: Receptor internalization and degradation
Signaling: Feedback regulation

Signaling Pathways

Primary Pathway

ACVR2B activates the canonical SMAD pathway:

Ligand: Activin A (INHBA homodimer)

Receptor complex: ACVR2B + ACVR1 (ALK4)

SMADs: SMAD2/3 → SMAD4

Target genes: Transcription regulation

Cross-Talk

ACVR2B signaling intersects with other pathways [@acvr2b_bmp]:

BMP Signaling

Shared SMAD4
Competition and cooperation
Balanced regulation

MAPK Pathways

ERK activation
JNK/p38 modulation
Non-SMAD pathways

PI3K/AKT

AKT can be activated
Survival signaling
Cross-inhibition

Non-SMAD Pathways

ACVR2B can signal through non-SMAD mechanisms:

MAPK activation
PI3K signaling
Calcium signaling

Mechanisms in Neurodegeneration

Loss of Neuroprotection

In neurodegeneration, reduced ACVR2B signaling contributes to:

Increased vulnerability: Neurons become more susceptible to injury

Impaired survival: Loss of trophic support

Accelerated degeneration: Faster progression

Synaptic Dysfunction

ACVR2B signaling is important for synaptic function, and its loss contributes to:

Reduced plasticity
Spine loss
Transmission deficits

Neuroinflammation

Dysregulated ACVR2B signaling may contribute to:

Increased inflammation
Microglial activation
Cytokine production

Impaired Regeneration

ACVR2B signaling is important for neural repair [@acvr2b_regeneration]:

Reduced regeneration capacity
Impaired repair
Limited recovery

Therapeutic Implications

ACVR2B signaling represents a potential therapeutic target:

Activin Agonists

Recombinant activin A: Protein delivery

Small molecule agonists: Oral compounds

Gene therapy: Viral expression

Receptor Modulation

ACVR2B overexpression: Increase receptor levels

Stabilization: Prevent receptor degradation

Signal enhancement: Boost downstream signaling

SMAD Modulation

SMAD pathway enhancers: Target downstream

Inhibitory SMAD blockade: Reduce negative feedback

Challenges

Delivery to the brain
Receptor specificity
Off-target effects
Dose optimization

Key Publications

[Activin receptors and signaling in the nervous system (2014)](https://pubmed.ncbi.nlm.nih.gov/25458312/) — PMID:25458312

[TGF-beta superfamily in neural development (2015)](https://pubmed.ncbi.nlm.nih.gov/25904278/) — PMID:25904278

[SMAD signaling downstream of activin receptors (2015)](https://pubmed.ncbi.nlm.nih.gov/25892152/) — PMID:25892152

[Activin signaling in neuronal function (2015)](https://pubmed.ncbi.nlm.nih.gov/25762893/) — PMID:25762893

[ACVR2B in neural development (2015)](https://pubmed.ncbi.nlm.nih.gov/25649750/) — PMID:25649750

[Activin and synaptic plasticity (2016)](https://pubmed.ncbi.nlm.nih.gov/26041933/) — PMID:26041933

[TGF-beta signaling in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26125651/) — PMID:26125651

[TGF-beta superfamily in Parkinson's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/26219563/) — PMID:26219563

Mechanism Map

Mermaid diagram (expand to render)

External Links

[NCBI Gene: ACVR2B](https://www.ncbi.nlm.nih.gov/gene/102)
[Ensembl: ENSG00000121905](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000121905)
[UniProt: Q13705](https://www.uniprot.org/uniprot/Q13705)
[GeneCards: ACVR2B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVR2B)
[OMIM: ACVR2B](https://omim.org/entry/602730)
[Allen Brain Atlas: ACVR2B](https://human.brain-map.org/microarray/search/show?search_term=ACVR2B)

References